Micanfa 50mg Injection

Expert advice for Micanfa Injection You may be monitored with liver function test during micafungin treatment and you may be asked to discontinue the drug if there are significant and persistent rise of liver enzymes. Inform your doctor if you have severe liver problems (eg. liver failure or hepatitis) as micafungin has potential risk of developing liver tumours with long term usage. Tell your doctor if you have hemolytic anaemia (anaemia due to breakdown of red blood cells) or haemolysis (breakdown of red blood cells), kidney problems (e.g. kidney failure and abnormal kidney function test), diabetes or rash. You should continue treatment with micafungin for atleast one week after two sequential negative blood cultures have been obtained and after resolution of clinical signs and symptoms of infection. Micafungin may lower the ability of your body to fight infection and/or may reduce the number of clot-forming cells in the blood. Avoid contact with people who have infections and activities that may cause bruising or injury. Tell your doctor if you are or planning to become pregnant or are breastfeeding.